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Long-term durability of aortic valve allografts may be enhanced by cellular 
capacities for regeneration and repair. To evaluate aortic valve graft 
production of an important structural protein, rat aortic roots were 
implanted heterotopically into the abdominal aorta of recipient rats. Grafts 
were either syngeneic or strongly allogeneic, were implanted either fresh or 
after cryopreservation, and were left in place 2 to 21 days after implanta- 
tion. A total of 80 aortic valve grafts and the corresponding 'native aortic 
valves were examined. The grafts were retrieved and immunocytochemically 
stained for the presence of procollagen, a precursor to collagen. Regardless 
of histocompatibility or preservation, grafts exhibited consistent procolla- 
gen presence that equaled or exceeded that seen in the corresponding native 
valves. Positive procollagen staining was predominantly in the aortic wall. 
The most prominent staining was near the hinge point of the valve leaflets, 
with no staining in the free portion of the leaflets. Staining with a-actin 
demonstrated vascular smooth muscle in sites remote from the areas 
positive for procollagen, which suggests that vascular smooth muscle was 
not responsible for the procollagen production. These findings indicate that 
cryopreservation is compatible with persistent fibroblast viability and in 
vivo protein synthesis by both syngeneic and allogeneic aortic valve grafts. 
(J Thorac Cardiovasc Surg 1997;113:102-7) 
L ong-term durability of aortic valve allografts may be enhanced by cellular capacities for regener- 
ation and repair. Persistence of cell viability in 
allograft valves has been described only sporadi- 
cally, and maintenance of important cell functions 
in vivo has not been documented. Questions of 
preservation techniques are particularly relevant 
in addressing allograft valve viability and function. 
It remains a subject of controversy whether cryo- 
preserved heart valves provide results better or 
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worse than valves subjected to minimal storage 
methods. 
Previous studies from this and other laboratories 
have examined the properties of endothelial cells 
in aortic valve grafts? -5 These previous investiga- 
tions have considered questions of endothelial cell 
persistence after cryopreservation, replication, 
and dye exclusion markers of viability. The fibro- 
blast population of the valve graft may- ultimately 
be more important than that of endothelial cells in 
determining structural stability and function. Fi- 
broblasts have a lower rate of replication than 
endothelial cells, have no specific cell markers, 
and are more difficult to subject to some of the 
quantitative analytic techniques applicable to the 
endothelium. The present investigation was un- 
dertaken to study one aspect of fibroblast viability, 
specifically the elaboration of procollagen, a pre- 
cursor molecule to collagen, and therefore an 
important structural protein. The study was de- 
signed to test two hypotheses: first, that cryo- 
preservation of aortic valve grafts is consistent 
with a capacity for procollagen synthesis imilar to 
that of the native aortic valve and, second, that 
allografts retain this capacity in a manner similar 
to that of isografts. 
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Fig. 1. Aortic valve graft stained for procollagen. Black precipitate (arrow) demonstrates positive staining 
for procollagen with highest concentration i  hinge region (H) of valve and minimal procollagen i  aortic 
wall (AW). There is no procollagen staining in free portion of valve leaflet (VL). 
Methods 
Experimental preparation. Heterotopic transplantation 
of aortic valve grafts was done as described originally by 
Yankah and colleagues) Male Lewis rats weighing 100 to 
125 gm underwent general anesthesia with intraperitoneal 
sodium pentobarbital (60 mg/kg body weight). Under sterile 
conditions, the heart and ascending aorta were excised and 
rinsed in heparinized 0.9% saline solution. The aortic valve 
graft was excised with a 1 mm cuff of ventficnlar muscle and 
a 5 mm portion of distal artery attached to permit construc- 
tion of the anastomoses. Some valves were transplanted 
immediately, whereas others were placed in heparinized 
saline solution and transported on ice to CryoLife, Inc. 
(Marietta, Ga.). The grafts underwent antibiotic sterilization, 
immersion in a graded series of dimethyl sulfoxide concen- 
trations to minimize ice crystal formation during cryopreser- 
ration, controlled-rate freezing at a rate of -1°C per 
minute, and storage in the vapor phase of liquid nitrogen 
between -135°C and -196°C until use. 
At the time of implantation, cryopreserved valves were 
thawed by immersion n 37 ° C saline solution and rinsed 
thoroughly before use. Fresh valves were left in hepa- 
rinized saline solution while the recipient animal was 
prepared. Aortic valve recipients were male rats weighing 
200 to 250 gm of the Lewis (syngeneic) or Brown Norway 
(strongly allogeneic, RT1 and non-RT1 incompatible) 
strains. Each recipient underwent sterile laparotomy and 
dissection of the abdominal aorta under a Nikon SMZ-10 
stereoscopic zoom microscope (Garden City, N.Y.) with a 
usual magnification of ×14. The recipient aorta was 
occluded proximally and distally- with vascular clamps and 
divided. An end-to-end anastomosis of the distal end of 
the valve graft to the distal end of the native aorta was 
done with 8-0 polypropylene suture. A second end-to-end 
anastomosis between the proximal end of the graft and 
the proximal end of the native aorta was constructed. 
None of the leaflets was included in the suture line. 
Instead, a concerted effort was made to allow the possi- 
bility that each leaflet remained mobile so that valve 
coaptation could occur. The presence or absence of leaflet 
mobility and coaptation is conjectural, however. The 
aortic clamps were removed, the abdomen closed, and the 
animals allowed to recover. 
Rats were allowed to survive for 2, 7, 14, or 21 days. 
Thus a total of 80 animals was studied: 20 for each of four 
durations of implantation, with 5 each receiving fresh 
isografts, fresh allografts, cryopreserved isografts, and 
cryopreserved allografts. At the time designated for graft 
retrieval, the rats received sodium pentobarbital (100 
mg/kg body weight) administered by intraperitoneal injec- 
tion. Rats underwent total body perfusion fixation via a 
femoral artery catheter. Animals were perfused with 40 ml 
of a fixation solution containing 60% methanol, 30% 
chloroform, and 10% glacial acetic acid. The perfusate 
was administered at 120 mm Hg after the jugular veins 
were divided to avoid excessive intravascular pressure. In 
addition to the 80 animals in the study group, 2 animals 
died before the designated time for tissue retrieval and 10 
that survived were found to have thrombosis of the graft. 
These animals were excluded from any further analysis. 
The grafts and native aortic roots were excised and stored 
for 24 hours in the fixative, dehydrated in graded alcohols 
and xylene, and embedded in paraffin. Eight-micrometer 
sections were obtained for histologic staining and analysis. 
All animals received humane care in compliance with 
the "Guide for the Care and Use of Laboratory Animals" 
published by the National Institutes of Health (NIH 
Publication No. 85-23, revised 1985). 
Histologie analysis. Presence of type I procollagen in 
native and grafted aortic valves and aortic walls was 
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Fig. 2. Serial section of aortic valve graft shown in Fig. 1 stained for c~-actin. Black precipitate (arrows), 
demonstrating presence of c~-actin, is confined to aortic wall (AW) and is remote from hinge region (H), 
site of most of procollagen staining. No c~-actin staining was observed in valve leaflet (VL). 
determined by the use of immunohistochemical staining 
as previously described. 6-9 Mouse monoclonal antibody 
SPI.D8 was obtained from the Developmental Studies 
Hybridoma Bank maintained by the Department of Phar- 
macology and Molecular Sciences, the Johns Hopkins 
University School of Medicine, and the Department of 
Biological Sciences, the University of Iowa, under con- 
tract N01-HD-6-2915 from the National Institute of Child 
Health and Human Development. This antibody is di- 
rected against ype I procollagen aminopeptide. For im- 
munocytochemistry studies, sections were deparaffinized 
and endogenous peroxidase activity was blocked with 
0.3% H202 for 5 minutes. Undiluted SPI.D8 antibody 
with 1% bovine serum albumin in 0.1 mol/L phosphate- 
buffered saline solution was applied for 60 minutes, and 
the specimen was washed with phosphate-buffered saline 
solution. The secondary antibody, biotinylated anti-mouse 
antibody (Vector Laboratories, Burlingame, Calif.) di- 
luted 1:500, was applied for 30 minutes. The specimen was 
washed and submitted for avidin-biotin amplification with 
the use of an ABC Elite Kit (Vector Laboratories) for 30 
minutes. The specimens were then washed and incubated 
with 0.1% 3',3'-diaminobenzidine (Sigma, St. Louis, Mo.) 
and H202 at 37 ° C for 5 to 10 minutes. This produced a 
brown reaction product. Nuclear counterstaining was 
done with methyl green for 2 minutes, followed by section 
dehydration and coverslip mounting. 
From the same blocks used to obtain sections for 
procollagen staining, serial tissue sections were also ob- 
tained for staining with an antibody to c~-actin. The 
c~-actin antibody used was a monoclonal mouse antibody 
to smooth muscle a-actin (Boehringer Mannheim, India- 
napolis, Ind.). This antibody recognizes mooth muscle 
cells of all types, including vascular smooth muscle, and 
reacts with the smooth muscle of many species, including 
the rat. l° Positive staining for c~-actin in proximity to areas 
positive for procollagen would suggest that smooth muscle 
cells could be responsible for the procollagen. Failure to 
demonstrate ~-actin in areas positive for procoUagen 
would suggest hat procollagen production is unlikely to 
be attributable to smooth muscle cells. 
Sections were examined by independent observers 
blinded as to the identity of the specimens. Sections were 
graded 0 (for no procollagen seen), 1 + (for isolated and 
scattered foci of procollagen), or 2+ (for larger and 
contiguous procollagen deposits). Grading was applied to 
each specimen on the basis of the largest concentration of
procollagen, regardless of the location within the speci- 
men. After histologic scoring was complete, the code was 
broken and the identity of the specimens was determined. 
For each rat, the histologic score of the native valve was 
compared with that of the graft. This method provides 
reproducible, qualitative valuation for procollagen pres- 
ence. 
Results 
Typical photomicrographs of specimens stained 
for procollagen and o~-actin are shown in Figs. 1 and 
2. By far, the greatest concentration of procollagen 
was in the hinge region of the valve, where the 
leaflet arose f rom the aortic wall. Some additional 
procollagen was less frequently observed in the 
aortic wall at sites more remote from the hinge 
region. Procollagen was never observed in the free 
port ion of the valve leaflets beyond the hinge region. 
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2 Days 7 Days 14 Days 21 Days 
Native Graft Native Graft Native Graft  Native Graft 
Fig. 3. Immunocytochemical procollagen score for fresh 
isograft group. Lines connect each aortic valve graft with 
its corresponding native valve. 
2 Days 7 Days 14 Days 21 Days 
Native Graft Native Graft Native Graft Native Graft 
Fig. 4. Immunocytochemical procollagen score for fresh 
allograft group. Lines connect each aortic valve graft with 
its corresponding native valve. 
Comparison of the two photomicrographs demon- 
strates that the area positive for procollagen is
remote from that positive for a-actin. This pattern 
of disparate areas of procollagen and a-actin stain- 
ing was observed in all specimens. The cryopre- 
served grafts were notable for the absence of endo- 
thelium, unlike the fresh grafts. This observation has 
been reported previously from this laboratory. 4 
The density of procollagen staining in the grafts 
equaled or exceeded that in the corresponding 
native aortic root in all cases. The procollagen 
grading was not substantially different at any of the 
time points studied. No differences in concentration 
or pattern of procollagen presence were observed in 
fresh grafts compared with cryopreserved grafts or 
in syngeneic ompared with allogeneic grafts. It is 
not possible from these observations to determine 
whether the presence or location of procollagen 
suggests an adaptive or a maladaptive process. A 
schematic representation f the procollagen grading 
is displayed in Figs. 3 through 6. 
Discussion 
Despite the tong-standing and increasingly popu- 
lar use of aortic allografts for the treatment of 
congenital and acquired heart disease, many basic 
questions remain regarding the cellular biology of 
these tissues. Whether the cells constituting the 
graft remain alive, whether they are capable of 
normal cellular processes, and whether they are 
affected by techniques of harvest, sterilization, a d 
storage have been vigorously debated. Establishing 
the answers to some of these questions on the basis 
of clinical evidence is difficult at best. Some of the 
difficulties in analyzing the reasons for graft dysfunc- 
tion are that the longevity of these grafts is generally 
good, and even grafts that fail may not be subjected 
to careful examination. Furthermore, "graft failure" 
often results not from tissue degeneration but in- 
stead is a consequence of surgeon error, the use of 
other materials that predispose to graft obstruction, 
or simple growth of the patient's heart beyond the 
size appropriate for the graft. 11-13 Accordingly, ex- 
perimental models of allograft valve implantation 
may provide a critical link between basic cell biology 
and clinical inferences. 
The use of the rat heterotopic graft model has 
provided useful information regarding the immuno- 
logic status and endothelial cell viability of aortic 
valve grafts. This experimental preparation exposes 
the graft to the same arterial oxygen content and pH 
that an orthotopic graft would have. Certain me- 
chanical properties, such as shear stress, pulsatility 
of pressure, and transvalvular gradients may be 
similar but are almost certainly not identical. Be- 
cause procollagen synthesis may be regulated in part 
by these mechanical forces, 7it is noteworthy that the 
experimental model in this study used a competent 
valve graft. Unlike previous tudies from this labo- 
ratory, in which one leaflet of the valve was inten- 
tionally made incompetent to reduce the frequency 
of thrombosis, 2-4 in this investigation the valve was 
implanted to make it possible for all leaflets to be 
mobile. Whether mobility and coaptation in fact 
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2 Days 7 Days 14 Days 21 Days 
Native Graft Native Graft  Native Graft  Native Graft 
Fig. 5. Immunocytochemical procollagen score for cryo- 
preserved isograft group. Lines connect each aortic valve 
graft with its corresponding ative valve. 
2 Days 7 Days 14 Days 21 Days 
Native Graft Native Graft  Native Graft  Native Graft 
Fig. 6. Immunocytochemical procollagen score for cryo- 
preserved allograft group. Lines connect each aortic valve 
graft with its corresponding ative valve. 
occurred is not known. Type I collagen, the type 
examined in this study and the most abundant 
procollagen subtype in the heart, is less affected by 
mechanical stimulation than is type III collagen, the 
second most abundant collagen type in the heart. TM 
Collagen is the predominant component of the 
extracellular matrix of the heart. Type I collagen does 
not arise from cardiac myocytes, but rather is pro- 
15 duced principally by the fibroblasts. Collagen biogen- 
esis does not occur intracellularly. Because collagen 
molecules spontaneously precipitate in a normal phys- 
iologic milieu, synthesis of the unaltered molecule 
would be incompatible with transport and assembly 
into fibrils) 6 Instead, collagen is synthesized and se- 
creted as procollagen, a precursor molecule that is 
soluble in intracellular and extracellular fluids. This 
permits transfer of procollagen to sites where the 
amino and carboxy terminal propeptides are removed 
and collagen polymerizes in a helical secondary struc- 
tute. 17 After secretion of procollagen, the propeptides 
are rapidly proteolyzed) 8 Antibodies to the propep- 
tide therefore identify sites of active collagen synthesis, 
whether associated with rapid growth, trauma, or 
inflammatory fibrosis, but do not localize to quiescent 
locations of past collagen assembly. 19 Because procol- 
lagen was demonstrated in aortic valve grafts at all 
intervals tudied from 2 to 21 days after implantation, 
it is concluded that this synthetic activity is occurring in 
the earliest postoperative p riod and continues for a 
prolonged period thereafter. 
Like the fibroblasts, vascular smooth muscle cells 
are capable of procollagen production. The obser- 
vation that a-actin staining did not coincide with 
procollagen staining indicates that vascular smooth 
muscle is not the source of the procollagen observed 
in the aortic valve grafts. This indirectly supports 
fibroblasts as the cell population responsible for 
procollagen. This cannot be directly confirmed be- 
cause of the lack of a specific marker for fibroblasts. 
It remains a possibility that vascular smooth muscle 
cells dedifferentiate into multipotential cells that 
synthesize procollagen while losing the ability to 
synthesize a-actin. Another intriguing possibility 
was suggested by the studies of Messier and col- 
leagues. 2° These investigators defined a population 
of aortic valve leaflet interstitial cells that exhibited 
properties of both fibroblasts and smooth muscle 
cells. They proposed designating these cells as 
"myofibroblasts" to emphasize their unique proper- 
ties and raised the hypothesis that those properties 
contribute to leaflet durability. 2° 
It seems reasonable that the observation of pro- 
collagen in the aortic valve graft can be taken as 
evidence for structural repair. This hypothesis would 
be consistent with the understanding that the hinge 
point of the valve leaflets, where procollagen was 
found in greatest abundance, is the site of maximum 
tissue stress and has the greatest requirements for 
repair. In the embryonic heart, the cardiac valve 
anlage demonstrates maximum collagen distribution 
in the valve ring area and arterial wall with little or 
no collagen in the commissural areas. 21 Thus the 
pattern of procollagen production in the valve grafts 
suggests a pattern similar to that seen in the devel- 
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oping valve. It may be speculated that the grafted 
aortic valve responds to surgical injury by means of  
a process reminiscent of early development.  
On the other hand, it is possible that procol lagen 
product ion is not directly associated with repair  but 
in fact presages a fibrous dysplasia. This may in turn 
lead to restr ict ion of leaflet mobility, calcification, 
and obstruct ion to flow. At  this t ime, it is not 
possible from histologic examinat ion to distinguish 
between procol lagen product ion leading to tissue 
support  and maintenance of structural integrity and 
that which results in dystrophic changes and im- 
pa i red valve function. Evidence that col lagen is 
increased in pathologic valves has been demon-  
strated by staining with ruthenium red, which delin- 
eates mucopolysacchar ide in the center of col lagen 
fibrils and surrounding the fibrils. 22 Procol lagen 
product ion is also upregulated in atherosclerot ic 
plaques, s At  least in atherosclerot ic plaque, procol-  
lagen product ion is not found to be upregulated in 
areas of active cel lular prol i ferat ion.  9 
The findings of this study suggest that fibroblast 
viability is retained in this model  of aortic valve grafts 
and that capacity for synthesis of an important struc- 
tural protein persists. Staining for procollagen in the 
graft was equal to or greater than that in the corre- 
sponding native valve, suggesting that procollagen 
synthesis is increased over baseline levels. This in- 
crease may be a response to surgical trauma, ischemia 
and reperfusion, growth factor elaboration, or other 
causes. The similarities in the fresh and cryopreserved 
grafts provide evidence that cryopreservation is com- 
patible with intact fibroblast function. Finally, the 
similarities in the syngeneic and allogeneic grafts indi- 
cate that histocompatibil ity differences do not affect 
these properties within the time frame studied. 
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